XML 25 R12.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Dow Inc. [Member]
Retained Earnings [Member]
The Dow Chemical Company
The Dow Chemical Company
Common Stock [Member]
The Dow Chemical Company
Additional Paid-in Capital [Member]
The Dow Chemical Company
Retained Earnings [Member]
The Dow Chemical Company
Accumulated Other Comprehensive Loss
The Dow Chemical Company
Noncontrolling Interests
Total Equity, Beginning at Dec. 31, 2023   $ 8 $ 8,880 $ 21,774 $ (7,681) $ 501     $ 0 $ 9,091 $ 17,495 $ (7,681)  
Stock Issued                   51      
Stock-based compensation and allocation of ESOP shares     199             199      
Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable     0             0      
Net income available for The Dow Chemical Company common stockholder $ 955     955       $ 962     962    
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             $ (1,477)            
Other     0 16             (16)    
Other comprehensive income (104)       (104)     (104)       (104)  
Total Equity, Ending at Jun. 30, 2024 18,800 8 9,012 21,739 (7,785) 482   19,002 0 9,341 16,964 (7,785) $ 482
Total Equity, Beginning at Mar. 31, 2024   8 8,942 21,796 (7,814) 492     0 9,220 17,214 (7,814)  
Stock Issued                   9      
Stock-based compensation and allocation of ESOP shares     112             112      
Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable     0             0      
Net income available for The Dow Chemical Company common stockholder 439     439       441     441    
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             (686)            
Other     0 5             (5)    
Other comprehensive income 29       29     29       29  
Total Equity, Ending at Jun. 30, 2024 18,800 8 9,012 21,739 (7,785) 482   19,002 0 9,341 16,964 (7,785) 482
The Dow Chemical Company’s stockholders’ equity 18,318             18,520          
The Dow Chemical Company’s stockholders’ equity 17,355             17,536          
Total Equity, Beginning at Dec. 31, 2024 17,851 8 9,203 20,909 (8,110) 496   18,032 0 9,626 16,020 (8,110)  
Stock Issued                   0      
Stock-based compensation and allocation of ESOP shares     196             196      
Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable     1,540             1,540      
Net income available for The Dow Chemical Company common stockholder (1,142)     (1,142)       (1,121)     (1,121)    
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             (985)            
Other     1 11             (12)    
Other comprehensive income 284       284     284       284  
Total Equity, Ending at Jun. 30, 2025 18,592 8 10,758 18,766 (7,826) 1,361   18,799 0 11,362 13,902 (7,826) 1,361
Total Equity, Beginning at Mar. 31, 2025   8 9,195 20,101 (7,956) 507     0 9,713 15,193 (7,956)  
Stock Issued                   0      
Stock-based compensation and allocation of ESOP shares     109             109      
Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable     1,540             1,540      
Net income available for The Dow Chemical Company common stockholder (835)     (835)       (816)     (816)    
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             $ (470)            
Other     1 4             (5)    
Other comprehensive income 130       130     130       130  
Total Equity, Ending at Jun. 30, 2025 18,592 $ 8 $ 10,758 $ 18,766 $ (7,826) $ 1,361   18,799 $ 0 $ 11,362 $ 13,902 $ (7,826) $ 1,361
The Dow Chemical Company’s stockholders’ equity $ 17,231             $ 17,438